A Molecular Biology And Phase II Study Of Lapatinib (GW572016) In Pediatric Patients With Recurrent Or Refractory Medulloblastoma, Malignant Glioma Or Ependymoma.
Phase of Trial: Phase I/II
Latest Information Update: 01 Sep 2013
At a glance
- Drugs Lapatinib (Primary)
- Indications Astrocytoma; Brain cancer; Ependymoma; Glioblastoma; Glioma; Gliosarcoma; Medulloblastoma; Oligodendroglioma; Primitive neuroectodermal tumours
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 03 Feb 2012 Actual patient number changed from 42 to 52 as reported by ClinicalTrials.gov.
- 10 Nov 2010 Actual end date (July 2010) added as reported by ClinicalTrials.gov.